Ravi Salgia has been appointed Chair for the Department of Medical Oncology and Therapeutics Research and the Associate Director for Clinical Sciences in City of Hope’s Comprehensive Cancer Center, Duarte, US. Dr. Salgia was on faculty at the Dana-Farber Cancer Institute for a decade and then moved to the University of Chicago as the Director of Thoracic Oncology Program, where he served as Professor of Medicine, Pathology, and Dermatology.
Sign up for news updates
Ravi Salgia, MD, PhD
|
|
Estimated Read Time:
1–2 minutes
Share this Article:
Recent Posts
-
August 11, 2026
-
August 11, 2026
-
August 11, 2026
-
August 11, 2026
View ILCN Archives
Provider Resources
Popular Articles
-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care